This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Milestones In Visius Surgical Theatre By Imris

- University of Virginia Striding Ahead with Intraoperative Imaging Suite -

WINNIPEG, May 8, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today reported on the preliminary successes that the University of Virginia (UVA) has achieved in their VISIUS Surgical Theatre.   UVA clinicians have treated over 50 patients in their VISIUS Surgical Theatre since its opening, achieving two important milestones in the use of their new intraoperative imaging capabilities.

Scott Lim, MD, Director of Pediatric & Adult Congenital Cardiac Catheterization, performed the very first cardiac intervention in a VISIUS Surgical Theatre when he treated a six-year old patient with a right heart catheter diagnosis using the combination of MR and x-ray imaging modalities of the suite.  Dr. Lim stated: "We are very pleased with the system for cardiac procedures.  In this case, we were able to acquire MR images in the cath lab immediately before the procedure, which eliminated the complexities of patient scheduling and patient movement through hospital.  In addition, by fusing MR images with angiography, we eliminated contrast agent and reduced 99% of the radiation we typically use on these patients."

Jeff Elias, MD, Associate Professor of Neurological Surgery and Neurology and Director of Stereotactic and Functional Neurosurgery, is the first to have performed stereotactic procedures in the VISIUS Surgical Theatre.  Using the rotational angiographic capabilities of the bi-plane, Dr. Elias creates 3D anatomical images of the brain which are then fused with images generated by the intraoperative MR to enhance his visualization of the brain.  Dr. Elias commented: "The combination of imaging modalities in this suite is critical for procedures treating Parkinson's or Essential Tremor.  The capability to fuse MR and angiographic images in real time improves our ability to plan surgery and operate with precision without transporting the patient."

The VISIUS Surgical Theatre at UVA features two state-of-the-art operating rooms connected by a room used for diagnostic imaging, and a ceiling-mounted MR scanner that moves between all three rooms.    Mark Shaffrey, MD, Chair, Department of Neurosurgery, who championed the effort to implement intraoperative MR at UVA and performed the first neurosurgical procedure in the suite, is encouraged by the initial successes of the clinical team: "The VISIUS Surgical Theatre is allowing us to combine biplane angiography with intraoperative MR imaging for extremely targeted, image-guided treatment and for visualization of anatomy to see that our surgical objectives are achieved.  The result is simple - better surgical results for our patients."

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

SOURCE IMRIS Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs